BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/12/2023 10:19:09 AM | Browse: 653 | Download: 1877
Publication Name World Journal of Gastroenterology
Manuscript ID 81164
Country China
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Chemistry, Medicinal
Manuscript Type Letter to the Editor
Article Title Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer
Manuscript Source Unsolicited Manuscript
All Author List Jun-Hao Huang, Wei Guo and Zhe Liu
ORCID
Author(s) ORCID Number
Jun-Hao Huang http://orcid.org/0000-0001-6501-599X
Wei Guo http://orcid.org/0000-0003-0375-0950
Zhe Liu http://orcid.org/0000-0003-2950-3966
Funding Agency and Grant Number
Corresponding Author Zhe Liu, MD, Doctor, Doctor, Professor, Surgeon, Department of Pancreatic-Biliary Surgery, The First Hospital of China Medical University, No. 155 Nanjing North Street, Heping District, Shenyang 110001, Liaoning Province, China. liuzhe4321@126.com
Key Words Pancreatic cancer; Chemotherapy; Targeted therapy; Gemcitabine; Drug; Combination
Core Tip In terms of the choice of chemotherapy regimen for pancreatic cancer, multi-drug chemotherapy is often applied in clinical practice. In general, the combination of chemotherapy and targeted therapy have better efficacy, but whether the combination of the two schemes is more effective than chemotherapy alone requires further investigations.
Publish Date 2023-01-12 10:19
Citation Huang JH, Guo W, Liu Z. Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer. World J Gastroenterol 2023; 29(3): 579-581
URL https://www.wjgnet.com/1007-9327/full/v29/i3/579.htm
DOI https://dx.doi.org/10.3748/wjg.v29.i3.579
Full Article (PDF) WJG-29-579.pdf
Full Article (Word) WJG-29-579.docx